| Financial Year |
March 31 2023 |
| Monetary Funds |
3,162,480,627.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
5,922,381,661.38 |
| Advances to Suppliers |
357,432,251.12 |
| Other Receivables |
16,262,464.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,632,521,368.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
449,975,581.24 |
| Total Current Assets |
14,342,096,932.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
193,639,446.71 |
| Investment Properties |
-- |
| Fixed Assetes |
4,461,038,644.18 |
| Under-construction Projects |
3,077,578,425.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
946,323,900.75 |
| R&D expenses |
-- |
| Goodwill |
224,168,279.14 |
| Long-Term Deferred and Prepaid Expenses |
45,437,368.69 |
| Deferred Income Tax Assets |
124,839,719.48 |
| Other Non-Current Assets |
2,073,204,824.01 |
| Sub-Total of Non-Current Assets |
11,620,206,062.09 |
| Total Assets |
25,962,302,994.44 |
| Short-Term Loans |
1,215,011,024.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
43,940,370.22 |
| Accounts Payable |
4,178,357,720.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
127,267,478.51 |
| Taxes Payable |
476,202,872.01 |
| Interest Payable |
-- |
| Dividend Payable |
30,442,915.71 |
| Other payables |
552,833,626.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
129,678,549.00 |
| Other Current Liabilities |
125,709,621.07 |
| Sub-Total of Current Liabilities |
7,820,702,430.41 |
| Long-term Loans |
1,061,132,352.88 |
| Bonds Payable |
3,191,562,441.19 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,569,826.48 |
| Deferred Income Tax Liabilities |
106,344,343.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,522,781,078.02 |
| Total Liabilities |
12,343,483,508.43 |
| Paid-In Capital(Or Share Stock) |
1,926,658,395.00 |
| Capital Surplus |
1,997,823,119.89 |
| Surplus Reserve |
569,954,271.44 |
| LESS:Treasury Stock |
546,326,212.54 |
| Undistributed Profits |
8,879,883,554.45 |
| Minority Stockholder's Interest |
330,754,502.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,288,064,983.39 |
| Owner's Equity（Stockholder's Equity） |
13,618,819,486.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
25,962,302,994.44 |
